Genera Biosystems Limited develops and commercializes multiplexed molecular diagnostic tests in Australia. The company develops molecular diagnostic tests based upon its proprietary AmpaSand bead-based technology that facilitates the multiplexing of tests by identifying individual clusters of beads within a larger pool. Its products include PapType, a molecular diagnostic test for the simultaneous detection and genotyping of high risk and low risk types of human papillomaviruses that cause cervical cancer or genital warts; and RTIplex, an automated assay for the simultaneous detection of viral and bacterial respiratory pathogens. The company is also developing STIplex and BBVplex multiplex assays for the detection of common sexually transmitted infections. It serves commercial pathology providers. Genera Biosystems Limited has a strategic commercial collaboration agreement with Beckman Coulter Life Sciences. The company is based in Scoresby, Australia.